Recent VCNX News
- Vaccinex, Inc. Announces $1.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules • GlobeNewswire Inc. • 03/27/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 09:19:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 03:10:30 PM
- Vaccinex Announces Multiple New Agreements for Access to ActivMAb® Antigen Virus Technology • GlobeNewswire Inc. • 02/21/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 01:06:03 PM
- Vaccinex, Inc. Announces Reverse Stock Split • GlobeNewswire Inc. • 02/15/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 09:30:34 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/13/2024 09:15:59 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/12/2024 09:22:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:34:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:32:53 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/09/2024 09:08:11 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 02/08/2024 01:20:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/07/2024 08:43:55 PM
- Vaccinex Announces Pricing of $3.7 Million PIPE Financing • GlobeNewswire Inc. • 02/07/2024 01:00:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 01/22/2024 05:15:30 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/19/2024 09:40:09 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 01/10/2024 10:16:22 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 01/08/2024 09:16:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/28/2023 09:31:17 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 12/28/2023 09:15:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/12/2023 09:31:18 PM
- Nasdaq Grants Vaccinex Extension Until March 4, 2024 to Regain Compliance with Listing Rule • GlobeNewswire Inc. • 12/04/2023 01:00:00 PM
- Vaccinex Reports Third Quarter 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 11/13/2023 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 12:46:15 PM
FEATURED POET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks • Mar 27, 2024 10:52 AM
Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors • EDXC • Mar 27, 2024 3:01 PM
Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules • AUVI • Mar 27, 2024 2:51 PM
Maybacks Global Entertainment Opens 23 More Stations in Important Major Cities • AHRO • Mar 27, 2024 9:00 AM
NxGen Brands Inc. Forecast to Deliver 140% Growth in Q1 2024 • NXGB • Mar 27, 2024 7:30 AM
Kona Gold Beverages, Inc. Strategic Advancements: Covert LLC Introduces Federally Legal D9 Gummies and Revamps Innovative eCommerce Platform, Propelling Toward $12 Million Annual Revenue Goal • KGKG • Mar 26, 2024 8:30 AM